Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Curevac N.V. buy shadow

Start price
€48.40
10.09.20
Target price
-
Performance (%)
-21.934%
Price
€37.78
25.09.20

According to shadow what are the pros and cons of Curevac N.V. for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
positive Cash Flow expected
Standard Investments for future growth
Valuable balance sheet
ROE higher than 10% per year
Normal challenges to pay loans and raise capital
Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Stable Large shareholder and/or long term investor
Top 10 in its market
Future proof or reliable business model
EBIT growth >5% per year expected
Some uniques
Growths faster than the competition
Medium risks for its business
Known brand
Cons
Sustainability is little important
Significant cyclical dependencies
Low dividend yield expected

Comments by shadow for this prediction

In the thread Curevac N.v. diskutieren

Buy Curevac N.V.